{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:14:56Z","timestamp":1785255296498,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital"},{"DOI":"10.13039\/501100005873","name":"Keliakialiitto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005873","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Finnish Society of Nephrology"},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gastrointestinal (GI) symptoms are common in end-stage kidney disease. Mounting evidence indicates that the intestine plays an important role in the pathogenesis of IgA nephropathy (IgAN). However, no studies have addressed the obvious question; do IgAN patients suffer from GI symptoms?<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Presence of GI symptoms and health-related quality of life were evaluated using the validated Gastrointestinal Symptom Rating Scale (GSRS) and Psychological General Well-Being (PGWB) questionnaires in 104 patients with kidney biopsy-verified IgAN and in 147 healthy controls. A person was regarded to experience \u2018increased GI symptoms\u2019 if the GSRS score exceeded plus 1 standard deviation of the mean of the corresponding score in the healthy controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>According to the GSRS total score, the IgAN patients had more GI symptoms than the healthy controls (2.0 vs. 1.7, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Female IgAN patients had higher GSRS total score than male patients (2.2 vs. 1.7, <jats:italic>p<\/jats:italic>\u2009=\u20090.001). More IgAN patients with preserved kidney function (eGFR\u2009&gt;\u200960ml\/min\/1.73m<jats:sup>2<\/jats:sup>) suffered from increased symptoms of diarrhoea (76 vs. 25%, <jats:italic>p<\/jats:italic>\u2009=\u20090.028), constipation (81 vs. 19%, <jats:italic>p<\/jats:italic>\u2009=\u20090.046) and reflux (85 vs. 15%, <jats:italic>p<\/jats:italic>\u2009=\u20090.004) than did IgAN patients with reduced kidney function (eGFR\u2009&lt;\u200960ml\/min\/1.73m<jats:sup>2<\/jats:sup>).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>IgAN patients and especially female IgAN patients experienced more GI symptoms than healthy controls. More prevalent GI symptoms were already observed before kidney function was clearly reduced. Systematic enquiry of GI symptoms might increase the standard of care among IgAN patients. Moreover, GI symptoms may provide clues for future studies that examine the pathophysiology of IgAN.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-022-03019-8","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T18:03:52Z","timestamp":1670522632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Presence of gastrointestinal symptoms in IgA nephropathy: a cross-sectional study"],"prefix":"10.1186","volume":"23","author":[{"given":"Jussi T.","family":"Pohjonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katri M.","family":"Kaukinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martti J.","family":"Metso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakel KK.","family":"Nurmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heini SA.","family":"Huhtala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka H.","family":"P\u00f6rsti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka T.","family":"Mustonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satu M.","family":"M\u00e4kel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"issue":"4","key":"3019_CR1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2215\/CJN.07420716","volume":"12","author":"JC Rodrigues","year":"2017","unstructured":"Rodrigues JC, Haas M, Reich HN. IgA nephropathy. Clin J Am Soc Nephrol. 2017;12(4):677\u201386.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"3019_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/ndt\/gfu343","volume":"30","author":"R Coppo","year":"2015","unstructured":"Coppo R. The intestine-renal connection in IgA nephropathy. Nephrol Dial Transplant. 2015;30(3):360\u20136.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"3019_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrneph.2015.208","volume":"12","author":"J Floege","year":"2016","unstructured":"Floege J, Feehally J. The mucosa-kidney axis in IgA nephropathy. Nat Rev Nephrol. 2016;12(3):147\u201356.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"3019_CR4","first-page":"286","volume":"63","author":"G Rostoker","year":"1993","unstructured":"Rostoker G, Wirquin V, Terzidis H, et al. Mucosal Immun Prim Glomerulonephritis Nephron. 1993;63(3):286\u201390.","journal-title":"Mucosal Immun Prim Glomerulonephritis Nephron"},{"issue":"6","key":"3019_CR5","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1046\/j.1523-1755.1999.00471.x","volume":"55","author":"I Rantala","year":"1999","unstructured":"Rantala I, Collin P, Holm K, Kainulainen H, Mustonen J, M\u00e4ki M. Small bowel T cells, HLA class II antigen DR, and GroEL stress protein in IgA nephropathy. Kidney Int. 1999;55(6):2274\u201380.","journal-title":"Kidney Int"},{"issue":"6","key":"3019_CR6","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1111\/j.1523-1755.2005.00324.x","volume":"67","author":"T Honkanen","year":"2005","unstructured":"Honkanen T, Mustonen J, Kainulainen H, et al. Small bowel cyclooxygenase 2 (COX-2) expression in patients with IgA nephropathy. Kidney Int. 2005;67(6):2187\u201395.","journal-title":"Kidney Int"},{"issue":"3","key":"3019_CR7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/ndt\/16.3.513","volume":"16","author":"G Rostoker","year":"2001","unstructured":"Rostoker G, Delchier JC, Chaumette MT. Increased intestinal intra-epithelial T lymphocytes in primary glomerulonephritis. A role of oral tolerance breakdown in the pathophysiology of human primary glomerulonephritides? Nephrol Dial Transplant. 2001;16(3):513\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"3019_CR8","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1111\/j.1572-0241.2002.06025.x","volume":"97","author":"P Collin","year":"2002","unstructured":"Collin P, Syrj\u00e4nen J, Partanen J, Pasternack A, Kaukinen K, Mustonen J. Celiac disease and HLA DQ in patients with IgA nephropathy. Am J Gastroenterol. 2002;97(10):2572\u20136.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"3019_CR9","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1053\/ajkd.2002.33387","volume":"39","author":"A Pierucci","year":"2002","unstructured":"Pierucci A, Fofi C, Bartoli B, et al. Antiendomysial antibodies in Berger\u2019s disease. Am J Kidney Dis. 2002;39(6):1176\u201382.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"3019_CR10","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/MCG.0b013e318284792e","volume":"47","author":"A Welander","year":"2013","unstructured":"Welander A, Sundelin B, Fored M, Ludvigsson JF. Increased risk of IgA nephropathy among individuals with celiac disease. J Clin Gastroenterol. 2013;47(8):678\u201383.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"3019_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.dld.2017.09.131","volume":"50","author":"R Nurmi","year":"2018","unstructured":"Nurmi R, Metso M, P\u00f6rsti I, et al. Celiac disease or positive tissue transglutaminase antibodies in patients undergoing renal biopsies. Dig Liver Dis. 2018;50(1):27\u201331.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"3019_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000511555","volume":"145","author":"R Nurmi","year":"2021","unstructured":"Nurmi R, Pohjonen J, Metso M, et al. Prevalence of Inflammatory Bowel Disease and Celiac Disease in Patients with IgA Nephropathy over Time. Nephron. 2021;145(1):78\u201384.","journal-title":"Nephron"},{"issue":"2","key":"3019_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2215\/CJN.04660513","volume":"9","author":"JM Ambruzs","year":"2014","unstructured":"Ambruzs JM, Walker PD, Larsen CP. The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease. Clin J Am Soc Nephrol. 2014;9(2):265\u201370.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"3019_CR14","first-page":"1","volume":"10","author":"D Corica","year":"2015","unstructured":"Corica D, Romano C. Renal involvement in inflammatory bowel diseases. J Crohns Colitis. 2015;10(2):1\u201310.","journal-title":"J Crohns Colitis"},{"issue":"5","key":"3019_CR15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/ckj\/sfz004","volume":"12","author":"J Pohjonen","year":"2019","unstructured":"Pohjonen J, Nurmi R, Metso M, et al. Inflammatory bowel disease in patients undergoing renal biopsies. Clin Kidney J. 2019;12(5):645\u201351.","journal-title":"Clin Kidney J"},{"issue":"2","key":"3019_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1681\/ASN.2020060848","volume":"32","author":"J Rehnberg","year":"2021","unstructured":"Rehnberg J, Symreng A, Ludvigsson JF, Emilsson L. Inflammatory Bowel Disease Is More Common in Patients with IgA Nephropathy and Predicts Progression of ESKD: A Swedish Population-Based Cohort Study. J Am Soc Nephrol. 2021 Feb;32(2):411\u201323.","journal-title":"J Am Soc Nephrol"},{"issue":"10084","key":"3019_CR17","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/S0140-6736(17)30550-0","volume":"389","author":"BC Fellstr\u00f6m","year":"2017","unstructured":"Fellstr\u00f6m BC, Barratt J, Cook H, et al. Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial. The Lancet. 2017;389(10084):2117\u201327.","journal-title":"The Lancet"},{"issue":"8","key":"3019_CR18","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nrneph.2010.84","volume":"6","author":"S Shirazian","year":"2010","unstructured":"Shirazian S, Radhakrishnan J. Gastrointestinal disorders and renal failure: Exploring the connection. Nat Rev Nephrol. 2010;6(8):480\u201392.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"3019_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/00365521.2020.1722217","volume":"55","author":"P Costa-Moreira","year":"2020","unstructured":"Costa-Moreira P, Vilas-Boas F, Teixeira Fraga A, Macedo G. Particular aspects of gastroenterological disorders in chronic kidney disease and end-stage renal disease patients: a clinically focused review. Scand J Gastroenterol. 2020;55(2):129\u201338.","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"3019_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ekir.2019.11.002","volume":"5","author":"K Sumida","year":"2020","unstructured":"Sumida K, Yamagata K, Kovesdy CP. Constipation in CKD. Kidney Int Rep. 2020;5(2):121\u201334.","journal-title":"Kidney Int Rep"},{"issue":"8","key":"3019_CR21","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/ndt\/17.8.1434","volume":"17","author":"H Strid","year":"2002","unstructured":"Strid H, Simr\u00e9n M, Johansson AC, Svedlund J, Samuelsson O, Bj\u00f6rnsson ES. The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well-being. Nephrol Dial Transplant. 2002;17(8):1434\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"3019_CR22","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1111\/j.1572-0241.2007.01321.x","volume":"102","author":"AE Cano","year":"2007","unstructured":"Cano AE, Neil AK, Kang JY, et al. Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis. Am J Gastroenterol. 2007;102(9):1990\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"3019_CR23","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/j.1432-2277.2010.01115.x","volume":"23","author":"C Ponticelli","year":"2010","unstructured":"Ponticelli C, Colombo D, Novara M, Basilisco G. Gastrointestinal symptoms impair quality of life in Italian renal transplant recipients but are under-recognized by physicians. Transpl Int. 2010;23(11):1126\u201334.","journal-title":"Transpl Int"},{"issue":"32","key":"3019_CR24","doi-asserted-by":"publisher","first-page":"11370","DOI":"10.3748\/wjg.v20.i32.11370","volume":"20","author":"R Dong","year":"2014","unstructured":"Dong R, Guo ZY, Ding JR, Zhou YY, Wu H. Gastrointestinal symptoms: A comparison between patients undergoing peritoneal dialysis and hemodialysis. World J Gastroenterol. 2014;20(32):11370\u20135.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"3019_CR25","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/nep.13243","volume":"23","author":"J Zuvela","year":"2018","unstructured":"Zuvela J, Trimingham C, le Leu R, et al. Gastrointestinal symptoms in patients receiving dialysis: A systematic review. Nephrology. 2018;23(8):718\u201327.","journal-title":"Nephrology"},{"issue":"5","key":"3019_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000494145","volume":"48","author":"G Kosmadakis","year":"2018","unstructured":"Kosmadakis G, Albaret J, da Costa Correia E, Somda F, Aguilera D. Gastrointestinal Disorders in Peritoneal Dialysis Patients. Am J Nephrol. 2018;48(5):319\u201325.","journal-title":"Am J Nephrol"},{"issue":"1","key":"3019_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ekir.2020.10.013","volume":"6","author":"S Chan","year":"2021","unstructured":"Chan S, Cao C, Pascoe EM, et al. Patient-Reported Gastrointestinal Symptoms and the Association With Quality of Life Following Kidney Transplantation. Kidney Int Rep. 2021;6(1):138\u201345.","journal-title":"Kidney Int Rep"},{"issue":"6","key":"3019_CR28","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/S0272-6386(97)90463-7","volume":"29","author":"M Rocco","year":"1997","unstructured":"Rocco M, Gassman JJ, Wang S, Kaplan RM. Cross-Sectional Study of Quality of Life and Symptoms in Chronic Renal Disease Patients: The Modification of Diet in Renal Disease Study. Am J Kidney Dis. 1997;29(6):888\u201396.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"3019_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-015-0209-z","volume":"16","author":"X Zhang","year":"2015","unstructured":"Zhang X, Bansal N, Go AS, Hsu CY. Gastrointestinal symptoms, inflammation and hypoalbuminemia in chronic kidney disease patients: A cross-sectional study. BMC Nephrol. 2015;16(1):1\u20138.","journal-title":"BMC Nephrol"},{"issue":"1","key":"3019_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/ndt\/gfm564","volume":"23","author":"O Wirta","year":"2008","unstructured":"Wirta O, Mustonen J, Helin H, Pasternack A. Incidence of biopsy-proven glomerulonephritis. Nephrol Dial Transplant. 2008;23(1):193\u2013200.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"3019_CR31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000166925","volume":"5","author":"J Mustonen","year":"1985","unstructured":"Mustonen J, Pasternack A, Helin H, Nikkil\u00e4 M. Clinicopathologic correlations in a series of 143 patients with IgA glomerulonephritis. Am J Nephrol. 1985;5(3):150\u20137.","journal-title":"Am J Nephrol"},{"issue":"7","key":"3019_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu8070429","volume":"8","author":"P Laurikka","year":"2016","unstructured":"Laurikka P, Salmi T, Collin P, Huhtala H, M\u00e4ki M, Kaukinen K, et al. Gastrointestinal symptoms in celiac disease patients on a long-term gluten-free diet. Nutrients. 2016;8(7):1\u201311.","journal-title":"Nutrients"},{"issue":"11","key":"3019_CR33","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.3109\/00365529509101605","volume":"30","author":"E Dimen\u00e4s","year":"1995","unstructured":"Dimen\u00e4s E, Glise H, Hallerb\u00e4ck B, et al. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol. 1995;30(11):1046\u201352.","journal-title":"Scand J Gastroenterol"},{"issue":"221","key":"3019_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3109\/00365529609095544","volume":"31","author":"E Dimen\u00e4s","year":"1996","unstructured":"Dimen\u00e4s E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl. 1996;31(221):8\u201313.","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"7","key":"3019_CR35","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11136-006-0053-5","volume":"15","author":"L Kleinman","year":"2006","unstructured":"Kleinman L, Kilburg A, Machnicki G, Faull R, Walker R, Prasad R, et al. Using GI-specific patient outcome measures in renal transplant patients: Validation of the GSRS and GIQLI. Qual Life Res. 2006;15(7):1223\u201332.","journal-title":"Qual Life Res"},{"issue":"4","key":"3019_CR36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1365-2036.2005.02574.x","volume":"22","author":"M Viljamaa","year":"2005","unstructured":"Viljamaa M, Collin P, Huhtala H, Siev\u00e4nen H, M\u00e4ki M, Kaukinen K. Is coeliac disease screening in risk groups justified? A fourteen-year follow-up with special focus on compliance and quality of life. Aliment Pharmacol Ther. 2005;22(4):317\u201324.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"3019_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.dld.2006.01.004","volume":"38","author":"S Roos","year":"2006","unstructured":"Roos S, K\u00e4rner A, Hallert C. Psychological well-being of adult coeliac patients treated for 10 years. Dig Liver Dis. 2006;38(3):177\u201380.","journal-title":"Dig Liver Dis"},{"key":"3019_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1471-230X-13-75","volume":"13","author":"P Paarlahti","year":"2013","unstructured":"Paarlahti P, Kurppa K, Ukkola A, et al. Predictors of persistent symptoms and reduced quality of life in treated coeliac disease patients: A large cross-sectional study. BMC Gastroenterol. 2013;13:75.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"3019_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF00846549","volume":"12","author":"KO Fagerstrom","year":"1989","unstructured":"Fagerstrom KO, Schneider NG. Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989;12(2):159\u201382.","journal-title":"J Behav Med"},{"issue":"6","key":"3019_CR40","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/00952990.2018.1456545","volume":"44","author":"JC Higgins-Biddle","year":"2018","unstructured":"Higgins-Biddle JC, Babor TF. A review of the Alcohol Use Disorders Identification Test (AUDIT), AUDIT-C, and USAUDIT for screening in the United States: Past issues and future directions. Am J Drug Alcohol Abuse. 2018;44(6):578\u201386.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"9","key":"3019_CR41","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"1","key":"3019_CR42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12882-022-02723-9","volume":"23","author":"C Yi","year":"2022","unstructured":"Yi C, Wang X, Ye H, Lin J, Yang X. Patient-reported gastrointestinal symptoms in patients with peritoneal dialysis: the prevalence, influence factors and association with quality of life. BMC Nephrol. 2022;23(1):99.","journal-title":"BMC Nephrol"},{"issue":"5","key":"3019_CR43","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1053\/j.gastro.2005.09.071","volume":"130","author":"L Chang","year":"2006","unstructured":"Chang L, Toner BB, Fukudo S, et al. Gender, Age, Society, Culture, and the Patient\u2019s Perspective in the Functional Gastrointestinal Disorders. Gastroenterology. 2006;130(5):1435\u201346.","journal-title":"Gastroenterology"},{"issue":"1","key":"3019_CR44","first-page":"61","volume":"18","author":"S Kahvecioglu","year":"2005","unstructured":"Kahvecioglu S, Akdag I, Kiyici M, et al. High prevalence of irritable bowel syndrome and upper gastrointestinal symptoms in patients with chronic renal failure. J Nephrol. 2005;18(1):61\u20136.","journal-title":"J Nephrol"},{"issue":"7","key":"3019_CR45","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1152\/ajpgi.00155.2012","volume":"303","author":"M Camilleri","year":"2012","unstructured":"Camilleri M, Lasch K, Zhou W. Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;303(7):775\u201385.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"3019_CR46","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1210\/jc.2013-2409","volume":"99","author":"AG Madariaga","year":"2014","unstructured":"Madariaga AG, Santos Palacios S, Guill\u00e9n-Grima F, Galofr\u00e9 JC. The incidence and prevalence of thyroid dysfunction in Europe: A meta-analysis. J Clin Endocrinol Metab. 2014;99(3):923\u201331.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3019_CR47","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/MCG.0b013e3181d6bc3e","volume":"44","author":"EC Ebert","year":"2010","unstructured":"Ebert EC. The thyroid and the gut. J Clin Gastroenterol. 2010;44(6):402\u20136.","journal-title":"J Clin Gastroenterol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-03019-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-03019-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-03019-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T19:08:14Z","timestamp":1670526494000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-03019-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3019"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-03019-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,8]]},"assertion":[{"value":"11 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol complied with the Helsinki Declaration standards and was approved by the Ethics Committee of the Tampere University Hospital (R18215). All study participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"395"}}